Dummy personkort bilde

Skogen, Bjørn

Institutt for medisinsk biologi
Engelsk flaggikon Samisk flaggikon

  • Kjær, Mette; Geisen, Christof; Akkøk, Cigdem Ahaein; Wikman, Agneta; Sachs, Ulrich; Bussel, James B.; Nielsen, Kaspar; Walles, Katarina; Curtis, Brian R.; Vidarsson, Gestur; Järås, Kerstin; Skogen, Bjørn. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia. Transfusion and Apheresis Science 2020; Volum 59:102712 (1). ISSN 1473-0502.s 1 - 6.s doi: 10.1016/j.transci.2019.102712.

  • Ahlen, Maria Therese; Heide, Gøril; Husebekk, Anne; Skogen, Bjørn; Kjeldsen-Kragh, Jens; Stuge, Tor Brynjar. The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypes. Scandinavian Journal of Immunology 2020; Volum 92:e12890. ISSN 0300-9475.s 1 - 12.s doi: 10.1111/sji.12890.

  • Dahl, Jesper; Skogen, Bjørn; Kjær, Mette; Husebekk, Anne; Kjeldsen-Kragh, Jens; Tiller, Heidi. A combined effect of anti-HPA-1a and anti-HLA Class I in pregnancy?. Transfusion 2020; Volum 60 (9). ISSN 0041-1132.s 2121 - 2129.s doi: 10.1111/trf.15944.

  • Zhi, Huiying; Ahlen, Maria Therese; Thinn, Aye Myat Myat; Weiler, Hartmut; Curtis, Brian R.; Skogen, Bjørn; Zhu, Jieqing; Newman, Peter J.. High-resolutionmappingofthepolyclonalimmuneresponsetothehuman platelet alloantigen HPA-1a (PlA1). Blood Advances 2018; Volum 2 (21). ISSN 2473-9529.s 3001 - 3011.s doi: 10.1182/bloodadvances.2018023341.

  • Tiller, Heidi; Husebekk, Anne; Ahlen, Maria Therese; Stuge, Tor Brynjar; Skogen, Bjørn Ragnar. Current perspectives on fetal and neonatal alloimmune thrombocytopenia - Increasing clinical concerns and new treatment opportunities. International Journal of Women's Health 2017; Volum 9. ISSN 1179-1411.s 223 - 234.s doi: 10.2147/IJWH.S90753.

  • Kjær, Mette; Tiller, Heidi; Heide, Gøril; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar; Husebekk, Anne. Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study. PLOS ONE 2017; Volum 12:0182957 (8). ISSN 1932-6203.s 1 - 9.s doi: 10.1371/journal.pone.0182957.

  • Dahl, Jesper; Refsum, Erle; Ahlen, Maria Therese; Egeland, Torstein; Jensen, Tore; Viken, Marte K; Stuge, Tor Brynjar; Acharya, Ganesh; Husebekk, Anne; Skogen, Bjørn Ragnar; Tiller, Heidi. Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia?Antibody specificity analysis using epitope data. Journal of Reproductive Immunology 2017; Volum 122. ISSN 0165-0378.s 1 - 9.s doi: 10.1016/j.jri.2017.06.003.

  • Eksteen, Mariana; Heide, Gøril; Tiller, Heidi; Zhou, Yan; Nedberg, Nora Hersoug; Martinez, Inigo Zubiavrre; Husebekk, Anne; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar; Kjær, Mette. Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: A laboratory study using an in vitro model. Reproductive Biology and Endocrinology 2017; Volum 15:28. ISSN 1477-7827.s 1 - 8.s doi: 10.1186/s12958-017-0245-6.

  • Dahl, J; Husebekk, Anne; Acharya, Ganesh; Flo, Kari; Stuge, Tor Brynjar; Skogen, Bjørn Ragnar; Straume, Bjørn; Tiller, Heidi. Maternal anti-HLA class I antibodies are associated with reduced birthweight in thrombocytopenic neonates. Journal of Reproductive Immunology 2016; Volum 113. ISSN 0165-0378.s 27 - 34.s doi: 10.1016/j.jri.2015.10.003.

  • Weng, Ying-Jan; Husebekk, Anne; Skogen, Bjørn Ragnar; Kjær, Mette; Lin, Liang-Tzung; Burnouf, Thierry. Anti-human platelet antigen-1α immunoglobulin G preparation intended to prevent fetal and neonatal alloimmune thrombocytopenia. PLOS ONE 2016; Volum 11 (9). ISSN 1932-6203.s doi: 10.1371/journal.pone.0162973.

  • Ahlen, Maria Therese; Husebekk, Anne; Killie, Ida Løken; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar. T cell responses to human platelet antigen-1a involve a unique form of indirect allorecognition. JCI Insight 2016; Volum Sep 8 (1). ISSN 2379-3708.s e86558 - .s doi: 10.1172/jci.insight.86558.

  • Tiller, Heidi; Husebekk, Anne; Skogen, Bjørn Ragnar; Kjeldsen-Kragh, Jens; Killie, Mette Kjær. True risk of fetal/neonatal alloimmune thrombocytopenia in subsequent pregnancies: a prospective observational follow-up study. BJOG: An International Journal of Obstetrics and Gynaecology 2016; Volum 123 (5). ISSN 1470-0328.s 738 - 744.s doi: 10.1111/1471-0528.13343.

  • Eksteen, Mariana; Tiller, Heidi; Averina, Maria; Heide, Gøril; Killie, Mette Kjær; Ghevaert, Cedric; Michaelsen, Terje Einar; Ihle, Øistein; Husebekk, Anne; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar. Characterization of a human platelet antigen-1a-specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancy. Journal of Immunology 2015; Volum 194 (12). ISSN 0022-1767.s 5751 - 5760.s doi: 10.4049/jimmunol.1401599.

  • Yougbaré, Issaka; Lang, Sean; Yang, Hong; Chen, Pingguo; Zhao, Xu; Tai, Wei-She; Zdravic, Darko; Vadasz, Brian; Li, Conglei; Piran, Siavash; Marshall, Alexandra; Zhu, Guangheng; Tiller, Heidi; Killie, Mette Kjær; Boyd, Shelley; Leong-Poi, Howard; Wen, Xiao-Yan; Skogen, Bjørn Ragnar; Adamson, S. Lee; Freedman, John; Ni, Heyu. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage. Journal of Clinical Investigation 2015; Volum 125 (4). ISSN 0021-9738.s 1545 - 1556.s doi: 10.1172/JCI77820.

  • Kapur, Rick; Kustiawan, Iwan; Vestrheim, Anne Cathrine; Koeleman, Carolien A. M.; Visser, Remco; Einarsdottir, Helga; Porcelijn, Leendert; Jackson, Dave; Kumpel, Belinda; Deelder, André M.; Blank, Dennis; Skogen, Bjørn Ragnar; Killie, Mette Kjær; Michaelsen, Terje Einar; De, Haas,Masja; Rispens, Theo; van der Schoot, Ellen; Wuhrer, Manfred; Vidarsson, Gestur. A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood 2014; Volum 123 (4). ISSN 0006-4971.s 471 - 480.s doi: 10.1182/blood-2013-09-527978.

  • Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar. Mechanisms and Prevention of Alloimmunization in Pregnancy. Obstetrical and Gynecological Survey 2013; Volum 68 (7). ISSN 0029-7828.s 526 - 532.s doi: 10.1097/OGX.0b013e3182947ce4.

  • Ahlen, Maria Therese; Husebekk, Anne; Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Olsson, Martin L.; Skogen, Bjørn Ragnar. The Development of Severe Neonatal Alloimmune Thrombocytopenia due to Anti-HPA-1a Antibodies Is Correlated to Maternal ABO Genotypes. (Fulltekst: http://www.hindawi.com/journals/cdi/2012/156867/ Clinical & Developmental Immunology 2012. ISSN 1740-2522.s doi: 10.1155/2012/156867.

  • Husebekk, Anne; El Ekiaby, M; Gorgy, G; Killie, Mette Kjær; Hansen, Camilla Uhlin; Salma, Wahida; Navarrete, C.; El Afandi, M; Skogen, Bjørn Ragnar; Ahlen, Maria Therese. Foetal/neonatal alloimmune thrombocytopenia in Egypt; human platelet antigen genotype frequencies and antibody detection and follow-up in pregnancies. Transfusion and Apheresis Science 2012; Volum 47 (3). ISSN 1473-0502.s 277 - 282.s doi: 10.1016/j.transci.2012.04.001.

  • Kjeldsen-Kragh, Jens; Ni, Heyu; Skogen, Bjørn Ragnar. Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia. Current opinion in hematology 2012; Volum 19 (6). ISSN 1065-6251.s 469 - 474.s doi: 10.1097/MOH.0b013e328358f86c.

  • Tiller, Heidi; Killie, Mette Kjær; Chen, Pingguo; Eksteen, Mariana; Husebekk, Anne; Skogen, Bjørn Ragnar; Kjeldsen-Kragh, Jens; Ni, Heyu. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model. Transfusion 2012; Volum 52 (7). ISSN 0041-1132.s 1446 - 1457.s doi: 10.1111/j.1537-2995.2011.03480.x.

  • Tiller, Heidi; Killie, Mette Kjær; Husebekk, Anne; Skogen, Bjørn Ragnar; Ni, Heyu; Kjeldsen-Kragh, Jens; Øian, Pål. Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys. Acta Obstetricia et Gynecologica Scandinavica 2012; Volum 91 (1). ISSN 0001-6349.s 79 - 86.s doi: 10.1111/j.1600-0412.2011.01269.x.

  • Stuge, Tor Brynjar; Skogen, Bjørn Ragnar; Ahlen, Maria Therese; Husebekk, Anne; Urbaniak, SJ; Bessos, H. The Cellular immunobiology associated with fetal and neonatal alloimmune thrombocytopenia. Transfusion and Apheresis Science 2011; Volum 45 (1). ISSN 1473-0502.s 53 - 59.s doi: 10.1016/j.transci.2011.06.003.

  • Killie, Mette Kjær; Salma, Wahida; Bertelsen, eirin listau; Skogen, Bjørn Ragnar; Husebekk, Anne. Quantitative MAIPA: Comparison of different MAIPA protocols. Transfusion and Apheresis Science 2010; Volum 43 (2). ISSN 1473-0502.s 149 - 154.s doi: 10.1016/j.transci.2010.07.001.

  • Husebekk, Anne; Ahlen, Maria Therese; Killie, Mette Kjær; Tiller, Heidi; Eksteen, Mariana; Killie, Ida Løken; Heide, Gøril; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar. Blood group antigens and immune responses-detailed knowledge is necessary to prevent immunization and to follow up immunized individuals. ISBT Science Series 2010; Volum 5 (1). ISSN 1751-2816.s 24 - 26.

  • Skogen, Bjørn Ragnar; Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Ahlen, Maria Therese; Tiller, Heidi; Stuge, Tor Brynjar; Husebekk, Anne. Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention. Expert Review of Hematology 2010; Volum 3 (5). ISSN 1747-4086.s 559 - 566.s doi: 10.1586/EHM.10.49.

  • Husebekk, Anne; Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar. Is it time to implement HPA-1 screening in pregnancy?. Current opinion in hematology 2009; Volum 16 (6). ISSN 1065-6251.s 497 - 502.s doi: 10.1097/MOH.0b013e3283317be9.

  • Skogen, Bjørn Ragnar; Husebekk, Anne; Killie, Mette Kjær; Kjeldsen-Kragh, J. Neonatal Alloimmune Thrombocytopenia is Not What It was A Lesson Learned from a Large Prospective Screening and Intervention Program. Scandinavian Journal of Immunology 2009; Volum 70 (6). ISSN 0300-9475.s 531 - 534.s doi: 10.1111/j.1365-3083.2009.02339.x.

  • Ahlen, Maria Therese; Husebekk, Anne; Killie, Mette Kjær; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar. T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells. Blood 2009; Volum 113 (16). ISSN 0006-4971.s 3838 - 3844.s doi: 10.1182/blood-2008-09-178475.

  • Tiller, Heidi; Killie, Mette Kjær; Skogen, Bjørn Ragnar; Øian, Pål; Husebekk, Anne. Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme. BJOG: An International Journal of Obstetrics and Gynaecology 2009; Volum 116 (4). ISSN 1470-0328.s 594 - 598.s doi: 10.1111/j.1471-0528.2008.02068.x.

  • Killie, Mette Kjær; Husebekk, Anne; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar. A prospective study of maternal anti-HPA1a antibody level as a potential predictor for alloimmune thrombocytopenia in the newborn. Haematologica 2008; Volum 93. ISSN 0390-6078.s doi: 10.3324/haematol.12515.

  • Kjeldsen-Kragh, J; Husebekk, Anne; Killie, Mette Kjær; Skogen, Bjørn Ragnar. Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme?. Transfusion and Apheresis Science 2008; Volum 38. ISSN 1473-0502.s 183 - 188.s doi: 10.1016/j.transci.2008.04.010.

  • Killie, MK; Kjeldsen-Kragh, J; Husebekk, Anne; Skogen, Bjørn Ragnar; Olsen, Jan Abel; Kristiansen, ivar sØnbØ. Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia. BJOG: An International Journal of Obstetrics and Gynaecology 2007; Volum 114. ISSN 1470-0328.s doi: 10.1111/j.1471-0528.2007.01289.x.

  • Killie, Mette Kjær; Husebekk, Anne; Kaplan, Cecilie; Taaning, Ellen; Skogen, Bjørn Ragnar. Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study. Transfusion 2007; Volum 47. ISSN 0041-1132.s doi: 10.1111/j.1537-2995.2007.01063.x.

  • Kaplan, C; Freedman, J; Foxcroft, Z; Husebekk, Anne; Metcalfe, P; Munin-Diaz, E; Ouwehand, W; Panzer, S; Rozman, P; Skogen, Bjørn Ragnar. Monoclonal platelet antigen capture assays (MAIPA) and reagents: a statement. Vox Sanguinis 2007; Volum 93. ISSN 0042-9007.s 298 - 299.s doi: 10.1111/j.1423-0410.2007.00943.x.

  • Kjeldsen-Kragh, Jens; Killie, Mette Kjær; Tomter, G; Golebiowska, E; Randen, I; Hauge, R; Aune, Berit; Øian, Pål; Oian, P; Dahl, Lauritz Bredrup; Pirhonen, J; Lindeman, R; Husby, H; Haugen, G; Grønn, M; Skogen, Bjørn Ragnar; Husebekk, Anne. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007; Volum 110. ISSN 0006-4971.s 833 - 839.s doi: 10.1182/blood-2006-08-040121.

  • Husebekk, Anne; Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar. Treatment and prevention of alloimmune thrombocytopenias. Hematology education 2007; Volum 1 (1). ISSN 1872-5503.s 294 - 298.

  • Husebekk, Anne; Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar. Screening of anti-HPA-1a antibodies in HPA-1a-negative mothers. ISBT Science Series 2007; Volum 2 (1). ISSN 1751-2816.s 111 - 113.

  • Valentin, N; Gagne, K; Kerdudou, N; Halle, L; Kaplan, C; Killie, Mette Kjær; Skogen, Bjørn Ragnar; Muller, JY; Bignon, JD. The alloimmune response to the human platelet antigen-1a is not related to maternal-fetal killer immunoglobulinlike receptor/HLA-Cw combinations. Transfusion 2007; Volum 47 (12). ISSN 0041-1132.s 2322 - 2329.s doi: 10.1111/j.1537-2995.2007.01450.x.

  • Skogen, Bjørn Ragnar; Husebekk, Anne. A strategy for platelet transfusion in patients with alloantibodies to platelets. Transfusion Alternatives in Transfusion Medicine 2006; Volum 8 (2). ISSN 1295-9022.s 114 - 120.

  • Jorde, Rolf; Saleh, Farahnaz Naghibi; Sundsfjord, Johan A; Haug|, E; Skogen, Bjørn Ragnar. Coeliac disease in subjects with secondary hyperparathyroidism. Scandinavian Journal of Gastroenterology 2005; Volum 40 (2). ISSN 0036-5521.s 178 - 82.

  • Gruber, Franz; Lamark, Trond; Ånonli, Aileeen Cathrine; Sovershaev, Mikhail; Olsen, M; Gedde-Dahl, T; Hjort-Hansen, H; Skogen, Bjørn Ragnar. Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL. Leukemia 2005; Volum 19. ISSN 0887-6924.s 2159 - 2165.

  • Killie, Mette K.; Kjeldsen-Kragh, J; Randen, I; Skogen, Bjørn Ragnar; Husebekk, Anne. Evaluation of a new flow cytometric HPA 1a screening method - A rapid and reliable tool for HPA 1a screening of blood donors and pregnant women. Transfusion and Apheresis Science 2004; Volum 30. ISSN 1473-0502.s 89 - 92.

  • Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Randen, Ingrid; Skogen, Bjørn; Husebekk, Anne. Evaluation of a new flow cytometric HPA 1a screening method. A rapid and reliable tool for HPA 1a screening of blood donors and pregnant women. Transfusion and Apheresis Science 2004; Volum 30 (2). ISSN 1473-0502.s 89 - 92.

  • Husebekk, Anne; Skaug, K; Kolstad, A; Dahl, Inger Marie; Gutteberg, Tore Jarl; Skogen, Bjørn Ragnar. Hepatitis B virus-infected peripheral blood progenitor cell harvests in liquid nitrogen freezer containing non-infectious products. Transfusion 2004; Volum 44 (6). ISSN 0041-1132.s 942 - 3.

  • Kjær, Mette; Kjeldsen-Kragh, Jens; Fiskum, Cathrine; Leinan, Irene; Skogen, Bjørn; Husebekk, Anne. Screening for fetal and neonatal alloimmune thrombocytopenia ? lessons learned from a Norwegian screening program. Acta Obstetricia et Gynecologica Scandinavica 2018; Volum 97 (6). ISSN 0001-6349.s 766 - 767.s doi: 10.1111/aogs.13320.

  • Tiller, Heidi; Fedorcsák, Péter; Skogen, Bjørn Ragnar. Old tools revisited give hope - new treatment option for families with a history of severe FNAIT complications.. Acta Obstetricia et Gynecologica Scandinavica 2016; Volum 95 (4). ISSN 0001-6349.s 486 - 487.s doi: 10.1111/aogs.12842.

  • Tiller, Heidi; Killie, Mette Kjær; Husebekk, Anne; Skogen, Bjørn Ragnar; Kjeldsen-Kragh, Jens. The natural course of HPA-1a-immunized subsequent pregnancies and clinical outcome of neonates. American Journal of Obstetrics and Gynecology 2014; Volum 210 (1). ISSN 0002-9378.s S89 - S89.

  • Killie, Ida Løken; Ahlen, Maria Therese; Husebekk, Anne; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar. Induction and detection of in vivo immune responses to HPA-1a in a novel murine model of fetal/neonatal alloimmune thrombocytopenia (FNAIT). European symposium on platelet and granulocyte immunology 2014-07-03 - 2014-07-06 2014.

  • Dahl, Jesper; Husebekk, Anne; Acharya, Ganesh; Flo, Kari; Stuge, Tor Brynjar; Skogen, Bjørn Ragnar; Straume, Bjørn; Tiller, Heidi. Maternal anti-HLA class 1 antibodies are associated with reduced birth weight in thrombocytopenic neonates. 39th Nordic Congress of Obstetrics and Gynecology 2014-06-10 - 2014-06-12 2014.

  • Heide, Gøril; Stuge, Tor Brynjar; Skogen, Bjørn Ragnar; Husebekk, Anne; Ahlen, Maria Therese. The DR7-DQ2 Haplotype in a Native Norwegian Population. Scandinavian Journal of Immunology 2013; Volum 77 (5). ISSN 0300-9475.s 429 - 430.s doi: 10.1111/sji.12031.

  • Killie, Ida Løken; Husebekk, Anne; Ahlen, Maria Therese; Roalso, M.; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar. ARE CURRENT MURINE MODELS OF FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA BRINGING US CLOSER TO A BETTER UNDERSTANDING OF PATHOPHYSIOLOGY AND TREATMENT OF THE DISEASE?. Vox Sanguinis 2013; Volum 105. ISSN 0042-9007.s 252 - 252.

  • Eksteen, Mariana; Killie, Mette Kjær; Husebekk, Anne; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar. A NOVEL HUMAN MONOCLONAL HPA-1A-SPECIFIC ANTIBODY IS A USEFUL TOOL FOR DIAGNOSTICS IN FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA. Vox Sanguinis 2013; Volum 105. ISSN 0042-9007.s 240 - 240.

  • Husebekk, Anne; Skogen, Bjørn Ragnar. Får 6 millioner Euro for å utvikle nyfødt vaksine. Universitetet i Tromsø 2012.

  • Skogen, Bjørn Ragnar. Ny vaksine kan redde liv. Nordlys 2012. ISSN 0805-5440.

  • Skogen, Bjørn Ragnar. Skal reddes med mammavaksine. VG : Verdens gang 2012. ISSN 0805-5203.s 32 - 33.

  • Skogen, Bjørn Ragnar. Trenger blod fra 500 kvinner. Nordlys 2012. ISSN 0805-5440.

  • Skogen, Bjørn Ragnar; Husebekk, Anne. Fikk nei to ganger før gjennombrudd. Inntervju Dagens Næringsliv 2012.s 16 - 17.

  • Husebekk, Anne; Tiller, Heidi; Killie, Mette Kjær; Eksteen, Mariana; Ahlen, Maria Therese; Stuge, Tor Brynjar; Ni, H; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar. TOWARDS A PROPHYLACTIC TREATMENT OF HPA-1A-RELATED FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAIT). Vox Sanguinis 2012; Volum 103. ISSN 0042-9007.s 48 - 48.

  • Tiller, Heidi; Edsteen, M; Husebekk, Anne; Skogen, Bjørn Ragnar; Killie, A; Chen, P; Ni, H; Kjeldsen-Kragh, Jens. Foetal and neonatal alloimmune thrombocytopenia (FNAIT) - immunological basis and prevention. Acta Obstetricia et Gynecologica Scandinavica 2012; Volum 91. ISSN 0001-6349.s 52 - 53.

  • Kjeldsen-Kragh, Jens; Husebekk, Anne; Killie, Mette Kjær; Skogen, Bjørn Ragnar. The pathophysiology of FNAIT cannot be deduced from highly selected retrospective data. Blood 2011; Volum 118 (9). ISSN 0006-4971.s 2638 - 2639.s doi: 10.1182/blood-2011-06-360404.

  • Husebekk, Anne; Ahlen, Maria Therese; Killie, Mette Kjær; Tiller, Heidi; Eksteen, Mariana; Killie, Ida Løken; Heide, Gøril; Skogen, Bjørn Ragnar; Kjeldsen-Kragh, Jens; Stuge, Tor Brynjar. MATERNAL ALLOIMMUNE RESPONSE DURING PREGNANCY: BRAKE OF MATERNAL TOLERANCE TO FETAL HUMAN PLATELET ANTIGEN 1A ANTIGEN MAY BE ASSOCIATED WITH REDUCED PLACENTAL FUNCTION. Placenta 2011; Volum 32 (9). ISSN 0143-4004.s A121 - A121.

  • Eksteen, Mariana; Tiller, Heidi; Husebekk, Anne; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar. GENERATION OF MONOCLONAL ANTI-HPA-1A ANTIBODIES BY IMMORTALIZATION OF MEMORY B CELLS FROM A WOMAN ALLOIMMUNIZED IN CONNECTION WITH PREGNANCY. Vox Sanguinis 2010; Volum 99. ISSN 0042-9007.s 52 - 53.

  • Tiller, Heidi; Chen, Pingguo; Skogen, Bjørn Ragnar; Killie, Mette Kjær; Husebekk, Anne; Eksteen, Mariana; Kjeldsen-Kragh, Jens; Ni, Heyu. Administration of Anti-Platelet Antibodies Prevents the Anti-Platelet Immune Response and Bleeding Complications of Neonatal Immune Thrombocytopenia in a Murine Model. Blood 2009; Volum 114 (22). ISSN 0006-4971.s 97 - 97.

  • Tiller, Heidi; Killie, Mette Kjær; Husebekk, Anne; Skogen, Bjørn Ragnar; Ni, Heyu; Kjeldsen-Kragh, Jens; Øian, Pål. Association Between Maternal Anti-HPA1a Antibodies and Birth Weight of the Newborn. Blood 2009; Volum 114 (22). ISSN 0006-4971.s 949 - 950.

  • Husebekk, Anne; Mk, K; Stuge, Tor Brynjar; Tiller, H; Mt, A; Kjeldsen-Kragh, J; Skogen, Bjørn Ragnar. The knowledge of the pathophysiology of fetal/neonatal alloimmune thrombocytopenia is of importance to prevent immunization and to handle the immunized pregnancies in order to prevent hemorrhage. Vox Sanguinis 2008; Volum 95. ISSN 0042-9007.

  • Husebekk, Anne; Killie, Mette Kjær; Stuge, T; Tiller, Heidi; Ahlen, MT; Kjeldsen-Kragh, Jens; Skogen, Bjørn. The knowledge of the pathophysiology of fetal/neonatal alloimmune thrombocytopenia is of importance to prevent immunization and to handle the immunized pregnancies in order to prevent hemorrhage. Vox Sanguinis 2008; Volum 95. ISSN 0042-9007.s 203 - 203.

  • Killie, MK; Kjeldsen-Kragh, J; Husebekk, Anne; Skogen, Bjørn Ragnar; Olsen, Jan Abel; Kristiansen, IS. Cost-effectiveness analysis of screening for neonatal alloimmune thrombocytopenia was based on invalid assumption - Reply. BJOG: An International Journal of Obstetrics and Gynaecology 2008; Volum 115. ISSN 1470-0328.s doi: 10.1111/j.1471-0528.2007.01612.x.

  • Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Husebekk, Anne; Skogen, Bjørn Ragnar; Olsen, Jan Abel; Kristiansen, ivar sØnbØ. Cost-effectiveness of screening for neonatal alloimmune thrombocytopenia was based on invalid assumption. Authors Reply. BJOG: An International Journal of Obstetrics and Gynaecology 2008. ISSN 1470-0328.

  • Husebekk, Anne; Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar. Treatment and prevention of alloimmune thrombocytopenias. 12th congress of the european hematology association 2007-06-07 - 2007-06-10 2007.

  • Husebekk, Anne; Killie, Mette Kjær; Skogen, Bjørn Ragnar; Kjeldsen-Kragh, Jens. Screening of anti-HPA-1a in HPA-1a negative mothers. Vox Sanguinis 2007; Volum 93. ISSN 0042-9007.s 18 - .

  • Ahlen, Maria Therese; Killie, Mette Kjær; Skogen, Bjørn Ragnar; Husebekk, Anne; Stuge, Tor Brynjar. Isolation and Characterization of CD4+ T Cells Specific for the HPA 1a Epitope Associated with Neonatal Alloimmune Thrombocytopenia. Blood 2007; Volum 110 (11). ISSN 0006-4971.s 623a - 624a.

  • Ahlen, Maria Therese; Killie, Mette Kjær; Husebekk, Anne; Kjeldsen-Kragh, Jens; Olsson, ML; Skogen, Bjørn Ragnar. The Development of Severe Anti-HPA 1a-Related Neonatal Alloimmune Thrombocytopenia Is Influenced by the Maternal ABO Type. Blood 2007; Volum 110 (11). ISSN 0006-4971.s 623a - 623a.

  • Husebekk, Anne; Killie, Mette Kjær; Skogen, Bjørn; Kjeldsen-Kragh, Jens. Screening of anti-HPA-1a in HPA-1a negative mothers. Vox Sanguinis 2007; Volum 93. ISSN 0042-9007.s 18 - 18.

  • Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Husebekk, Anne; Skogen, Bjørn; Olsen, Jan Abel; Kristiansen, Ivar Sønbø. Author response to: Cost-effectiveness analysis of screening for neonatal alloimmune thrombocytopenia was based on invalid assumption. BJOG: An International Journal of Obstetrics and Gynaecology 2007; Volum 115. ISSN 1470-0328.s 413 - 414.

  • Ahlen, Maria Therese; Killie, Mette K.; Kjeldsen-Kragh, Jens; Husebekk, Anne; Olsson, ML; Skogen, Bjørn Ragnar. HPA-1a immuniserte mødre med blodtype A har større risiko for å føde barn med alvorlig NAIT enn mødre med blodtype 0. Regional forskningskonferanse innen medisin og helse 2006-11-01 - 2006-11-02 2006.

  • Killie, Mette K.; Kjeldsen-Kragh, Jens; Husebekk, Anne; Skogen, Bjørn Ragnar; Olsen, Jan Abel; Kristiansen, Ivar Sønbø. Cost-utility analysis of antenatal screening for Neonatal Alloimmune Thrombocytopenia. Regional forskningskonferanse innen medisin og helse 2006.

  • Kjeldsen-Kragh, Jens; Killie, Mette K.; Tomter, G; Golebiowska, E; Pedersen, Helene; Randen, I; Hauge, R; Aune, Berit; Øian, Pål; Dahl, Lauritz Bredrup; Pirhonen, J; Lindemann, R; Husby, H; Grønn, M; Skogen, Bjørn Ragnar; Husebekk, Anne. A screening and intervention program that significantly reduces mortality and serious morbidity associated with grave neonatal alloimmune thrombocytopenia. Regional forskningskonferanse innen medisin og helse 2006.

  • Husebekk, Anne; Killie, Mette K.; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar. General overview over screening programs. Vox Sanguinis 2006; Volum 91. ISSN 0042-9007.s 15 - 15.

  • Kjeldsen-Kragh, Jens; Killie, Mette K.; Skogen, Bjørn Ragnar; Husebekk, Anne. A screening and intervention program that significantly reduces mortality and serious morbidity associated with grave neonatal alloimmune thrombocytopenia. Vox Sanguinis 2006; Volum 91. ISSN 0042-9007.s 15 - 15.

  • Killie, Mette K.; Kjeldsen-Kragh, Jens; Husebekk, Anne; Skogen, Bjørn Ragnar; Olsen, Jan Abel; Kristiansen, ivar sØnbØ. Cost-utility analysis of antenatal screening for neonatal alloimmune thrombocytopenia. Vox Sanguinis 2006; Volum 91. ISSN 0042-9007.s 263 - 263.

  • Kjeldsen-Kragh, Jens; Killie, Mette K.; Skogen, Bjørn Ragnar; Husebekk, Anne. A sreening and intervention program that significantly reduces mortality and serious morbidity associated with grave neonatal alloimmune thrombocytopenia. 9th European Symposium on Platelet and Granulocyte Immunobiology 2006-06-15 - 2006-06-18 2006.

  • Kjeldsen-Kragh, Jens; Killie, Mette K.; Tomter, G; Golebiowska, E; Pedersen, H; Randen, I; Hauge, R; Aune, Berit; Øian, Pål; Dahl, Lauritz Bredrup; Pirhonen, J; Lindemann, R; Husby, H; Grønn, M; Skogen, Bjørn Ragnar; Husebekk, Anne. A screening and intervention program that significantly reduces mortality and serious morbidity associated with grave neonatal alloimmune thrombocytopenia. Regional forskningskonferanse innen medisin og helse 2006-11-01 - 2006-11-02 2006.

  • Husebekk, Anne; Killie, Mette K.; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar. General overview over screening programs. 9th European Symposium on platelet and Granulocyte Immunobiology 2006-06-15 - 2006-06-18 2006.

  • Killie, Mette K.; Kjeldsen-Kragh, Jens; Husebekk, Anne; Skogen, Bjørn Ragnar; Olsen, Jan Abel; Kristiansen, Ivar Sønbø. Cost-utility analysis of antenatal screening for Neonatal Alloimmune Thrombocytopenia. Regional forskningskonferanse innen medisin og helse 2006-11-01 - 2006-11-02 2006.

  • Gruber, F; Hansen, Hh; Olsen, M; Eggen, L; Skogen, Bjørn Ragnar; Gedde-dahl, T; Lundan, T; Porkka, K; Simonsson, B; Markevärn, B; Wadenvik, H; Stenke, L. Quantitative analysis of BCR-ABL mutations associated with imatinib treatment in CML. american society of hematology 2005-12-10 - 2005-12-13 2005.

  • Skogen, Bjørn Ragnar. Struktur og ressurser i transfusjonstjenesten i Helse Nord. Årsmøte i plasmafraksjoneringsprosjektet 2005-02-09 - 2005-02-09 2005.

  • Skogen, Bjørn Ragnar. Tanker fra de regionale helseforetakene. lederdagene 2005, NITO 2005-10-24 - 2005-10-26 2005.

  • Skogen, Bjørn Ragnar. Nye diagnostiske metoder i transfusjonsmedisin. Nasjonal Blodbankkonferanse 2005-09-22 - 2005-09-24 2005.

  • Husebekk, Anne; Kjeldsen-Kragh, J; Killie, Mette K.; Skogen, Bjørn Ragnar. Thrombocyte immunology – the role of antibodies related to transfusion and pregnancy. 15th ISBT European regional Conference 2005-07-04 - 2005-07-06 2005.

  • Kjeldsen-Kragh, J; Killie, Mette K.; Tomter, G; Golebiowska, E; Pedersen, H; Randen, I; Hauge, R; Aune, B; Oian, P; Dahl, LB; Pirhonen, J; Svennigsen, L; Wergeland, H; Lindeman, R; Husby, H; Gronn, M; Skogen, Bjørn Ragnar; Husebekk, Anne. A screening and intervention program reducing mortality and serious morbidity associated with neonatal alloimmune thrombocytopenia. American society of hematology 2005-12-10 - 2005-12-13 2005.

  • Aune, B.; Kjeldsen-Kragh, Jens; Killie, Mette Kjær; Øian, P; Dahl, L. B.; Pirhonen, Jouko; Svenningsen, Leif; WERGELAND, HÅKON; Lindemann, Rolf; Husby, H; Haugen, Guttorm; Grønn, Morten; Skogen, Bjørn; Husebekk, Anne. An intervention program for reducing morbidity and mortality associated with neonatal allo-immune thrombocytopenic purpura (NAITP). the 34th Congress of Nordic Federation of Societies of Obstretics and Gynecology 2004-06-12 - 2004-06-15 2004.

  • Kjeldsen-Kragh, Jens; Killie, Mette Kjær; Aune, B.; Oian, P; Dahl, L; Pirhonen, Jouko; Svenningsen, Leif; WERGELAND, HÅKON; Lindemann, Rolf; Husby, H; Haugen, Guttorm; Grønn, Morten; Skogen, Bjørn; Husebekk, Anne. An intervention program for reducing morbidity and mortality associated with neonatal alloimmune thrombocytopenic purpura (NAITP). Platelets 2004; Volum 15. ISSN 0953-7104.s 250 - .

  • Killie, Mette Kjær; Husebekk, Anne; Kjeldsen-Kragh, Jens; Skogen, Bjørn. The natural course of anti-HPA 1a antibody levels in subsequent non-compatible pregnancies. Platelets 2004; Volum 15. ISSN 0953-7104.s 250 - .

  • Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Skogen, Bjørn; Husebekk, Anne. Maternal anti-HPA 1a antibody level as predictive value in neonatal alloimmune thrombocytopenic purpura (NAITP). Blood 2004; Volum 104. ISSN 0006-4971.s 570a - 571a.

  • Gruber, Franz; Lamark, Trond; Olsen, M; Hokkland, K; Skogen, Bjørn Ragnar. A RQ-PCR approach for quantitation of Glivec resistance associated mutations. Blood 2003; Volum 102. ISSN 0006-4971.s 416A - 417A.

  • Kjær, Mette; Kjeldsen-Kragh, Jens; Fiskum, Cathrine; Leinan, Irene; Skogen, Bjørn; Husebekk, Anne. Screening for fetal and neonatal alloimmune thrombocytopenia ? lessons learned from a Norwegian screening program. Acta Obstetricia et Gynecologica Scandinavica 2018; Volum 97 (6). ISSN 0001-6349.s 766 - 767.s doi: 10.1111/aogs.13320.

  • Tiller, Heidi; Fedorcsák, Péter; Skogen, Bjørn Ragnar. Old tools revisited give hope - new treatment option for families with a history of severe FNAIT complications.. Acta Obstetricia et Gynecologica Scandinavica 2016; Volum 95 (4). ISSN 0001-6349.s 486 - 487.s doi: 10.1111/aogs.12842.

  • Tiller, Heidi; Killie, Mette Kjær; Husebekk, Anne; Skogen, Bjørn Ragnar; Kjeldsen-Kragh, Jens. The natural course of HPA-1a-immunized subsequent pregnancies and clinical outcome of neonates. American Journal of Obstetrics and Gynecology 2014; Volum 210 (1). ISSN 0002-9378.s S89 - S89.

  • Killie, Ida Løken; Ahlen, Maria Therese; Husebekk, Anne; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar. Induction and detection of in vivo immune responses to HPA-1a in a novel murine model of fetal/neonatal alloimmune thrombocytopenia (FNAIT). European symposium on platelet and granulocyte immunology 2014-07-03 - 2014-07-06 2014.

  • Dahl, Jesper; Husebekk, Anne; Acharya, Ganesh; Flo, Kari; Stuge, Tor Brynjar; Skogen, Bjørn Ragnar; Straume, Bjørn; Tiller, Heidi. Maternal anti-HLA class 1 antibodies are associated with reduced birth weight in thrombocytopenic neonates. 39th Nordic Congress of Obstetrics and Gynecology 2014-06-10 - 2014-06-12 2014.

  • Heide, Gøril; Stuge, Tor Brynjar; Skogen, Bjørn Ragnar; Husebekk, Anne; Ahlen, Maria Therese. The DR7-DQ2 Haplotype in a Native Norwegian Population. Scandinavian Journal of Immunology 2013; Volum 77 (5). ISSN 0300-9475.s 429 - 430.s doi: 10.1111/sji.12031.

  • Killie, Ida Løken; Husebekk, Anne; Ahlen, Maria Therese; Roalso, M.; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar. ARE CURRENT MURINE MODELS OF FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA BRINGING US CLOSER TO A BETTER UNDERSTANDING OF PATHOPHYSIOLOGY AND TREATMENT OF THE DISEASE?. Vox Sanguinis 2013; Volum 105. ISSN 0042-9007.s 252 - 252.

  • Eksteen, Mariana; Killie, Mette Kjær; Husebekk, Anne; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar. A NOVEL HUMAN MONOCLONAL HPA-1A-SPECIFIC ANTIBODY IS A USEFUL TOOL FOR DIAGNOSTICS IN FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA. Vox Sanguinis 2013; Volum 105. ISSN 0042-9007.s 240 - 240.

  • Husebekk, Anne; Skogen, Bjørn Ragnar. Får 6 millioner Euro for å utvikle nyfødt vaksine. Universitetet i Tromsø 2012.

  • Skogen, Bjørn Ragnar. Ny vaksine kan redde liv. Nordlys 2012. ISSN 0805-5440.

  • Skogen, Bjørn Ragnar. Skal reddes med mammavaksine. VG : Verdens gang 2012. ISSN 0805-5203.s 32 - 33.

  • Skogen, Bjørn Ragnar. Trenger blod fra 500 kvinner. Nordlys 2012. ISSN 0805-5440.

  • Skogen, Bjørn Ragnar; Husebekk, Anne. Fikk nei to ganger før gjennombrudd. Inntervju Dagens Næringsliv 2012.s 16 - 17.

  • Husebekk, Anne; Tiller, Heidi; Killie, Mette Kjær; Eksteen, Mariana; Ahlen, Maria Therese; Stuge, Tor Brynjar; Ni, H; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar. TOWARDS A PROPHYLACTIC TREATMENT OF HPA-1A-RELATED FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAIT). Vox Sanguinis 2012; Volum 103. ISSN 0042-9007.s 48 - 48.

  • Tiller, Heidi; Edsteen, M; Husebekk, Anne; Skogen, Bjørn Ragnar; Killie, A; Chen, P; Ni, H; Kjeldsen-Kragh, Jens. Foetal and neonatal alloimmune thrombocytopenia (FNAIT) - immunological basis and prevention. Acta Obstetricia et Gynecologica Scandinavica 2012; Volum 91. ISSN 0001-6349.s 52 - 53.

  • Kjeldsen-Kragh, Jens; Husebekk, Anne; Killie, Mette Kjær; Skogen, Bjørn Ragnar. The pathophysiology of FNAIT cannot be deduced from highly selected retrospective data. Blood 2011; Volum 118 (9). ISSN 0006-4971.s 2638 - 2639.s doi: 10.1182/blood-2011-06-360404.

  • Husebekk, Anne; Ahlen, Maria Therese; Killie, Mette Kjær; Tiller, Heidi; Eksteen, Mariana; Killie, Ida Løken; Heide, Gøril; Skogen, Bjørn Ragnar; Kjeldsen-Kragh, Jens; Stuge, Tor Brynjar. MATERNAL ALLOIMMUNE RESPONSE DURING PREGNANCY: BRAKE OF MATERNAL TOLERANCE TO FETAL HUMAN PLATELET ANTIGEN 1A ANTIGEN MAY BE ASSOCIATED WITH REDUCED PLACENTAL FUNCTION. Placenta 2011; Volum 32 (9). ISSN 0143-4004.s A121 - A121.

  • Eksteen, Mariana; Tiller, Heidi; Husebekk, Anne; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar. GENERATION OF MONOCLONAL ANTI-HPA-1A ANTIBODIES BY IMMORTALIZATION OF MEMORY B CELLS FROM A WOMAN ALLOIMMUNIZED IN CONNECTION WITH PREGNANCY. Vox Sanguinis 2010; Volum 99. ISSN 0042-9007.s 52 - 53.

  • Tiller, Heidi; Chen, Pingguo; Skogen, Bjørn Ragnar; Killie, Mette Kjær; Husebekk, Anne; Eksteen, Mariana; Kjeldsen-Kragh, Jens; Ni, Heyu. Administration of Anti-Platelet Antibodies Prevents the Anti-Platelet Immune Response and Bleeding Complications of Neonatal Immune Thrombocytopenia in a Murine Model. Blood 2009; Volum 114 (22). ISSN 0006-4971.s 97 - 97.

  • Tiller, Heidi; Killie, Mette Kjær; Husebekk, Anne; Skogen, Bjørn Ragnar; Ni, Heyu; Kjeldsen-Kragh, Jens; Øian, Pål. Association Between Maternal Anti-HPA1a Antibodies and Birth Weight of the Newborn. Blood 2009; Volum 114 (22). ISSN 0006-4971.s 949 - 950.

  • Husebekk, Anne; Mk, K; Stuge, Tor Brynjar; Tiller, H; Mt, A; Kjeldsen-Kragh, J; Skogen, Bjørn Ragnar. The knowledge of the pathophysiology of fetal/neonatal alloimmune thrombocytopenia is of importance to prevent immunization and to handle the immunized pregnancies in order to prevent hemorrhage. Vox Sanguinis 2008; Volum 95. ISSN 0042-9007.

  • Husebekk, Anne; Killie, Mette Kjær; Stuge, T; Tiller, Heidi; Ahlen, MT; Kjeldsen-Kragh, Jens; Skogen, Bjørn. The knowledge of the pathophysiology of fetal/neonatal alloimmune thrombocytopenia is of importance to prevent immunization and to handle the immunized pregnancies in order to prevent hemorrhage. Vox Sanguinis 2008; Volum 95. ISSN 0042-9007.s 203 - 203.

  • Killie, MK; Kjeldsen-Kragh, J; Husebekk, Anne; Skogen, Bjørn Ragnar; Olsen, Jan Abel; Kristiansen, IS. Cost-effectiveness analysis of screening for neonatal alloimmune thrombocytopenia was based on invalid assumption - Reply. BJOG: An International Journal of Obstetrics and Gynaecology 2008; Volum 115. ISSN 1470-0328.s doi: 10.1111/j.1471-0528.2007.01612.x.

  • Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Husebekk, Anne; Skogen, Bjørn Ragnar; Olsen, Jan Abel; Kristiansen, ivar sØnbØ. Cost-effectiveness of screening for neonatal alloimmune thrombocytopenia was based on invalid assumption. Authors Reply. BJOG: An International Journal of Obstetrics and Gynaecology 2008. ISSN 1470-0328.

  • Husebekk, Anne; Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar. Treatment and prevention of alloimmune thrombocytopenias. 12th congress of the european hematology association 2007-06-07 - 2007-06-10 2007.

  • Husebekk, Anne; Killie, Mette Kjær; Skogen, Bjørn Ragnar; Kjeldsen-Kragh, Jens. Screening of anti-HPA-1a in HPA-1a negative mothers. Vox Sanguinis 2007; Volum 93. ISSN 0042-9007.s 18 - .

  • Ahlen, Maria Therese; Killie, Mette Kjær; Skogen, Bjørn Ragnar; Husebekk, Anne; Stuge, Tor Brynjar. Isolation and Characterization of CD4+ T Cells Specific for the HPA 1a Epitope Associated with Neonatal Alloimmune Thrombocytopenia. Blood 2007; Volum 110 (11). ISSN 0006-4971.s 623a - 624a.

  • Ahlen, Maria Therese; Killie, Mette Kjær; Husebekk, Anne; Kjeldsen-Kragh, Jens; Olsson, ML; Skogen, Bjørn Ragnar. The Development of Severe Anti-HPA 1a-Related Neonatal Alloimmune Thrombocytopenia Is Influenced by the Maternal ABO Type. Blood 2007; Volum 110 (11). ISSN 0006-4971.s 623a - 623a.

  • Husebekk, Anne; Killie, Mette Kjær; Skogen, Bjørn; Kjeldsen-Kragh, Jens. Screening of anti-HPA-1a in HPA-1a negative mothers. Vox Sanguinis 2007; Volum 93. ISSN 0042-9007.s 18 - 18.

  • Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Husebekk, Anne; Skogen, Bjørn; Olsen, Jan Abel; Kristiansen, Ivar Sønbø. Author response to: Cost-effectiveness analysis of screening for neonatal alloimmune thrombocytopenia was based on invalid assumption. BJOG: An International Journal of Obstetrics and Gynaecology 2007; Volum 115. ISSN 1470-0328.s 413 - 414.

  • Ahlen, Maria Therese; Killie, Mette K.; Kjeldsen-Kragh, Jens; Husebekk, Anne; Olsson, ML; Skogen, Bjørn Ragnar. HPA-1a immuniserte mødre med blodtype A har større risiko for å føde barn med alvorlig NAIT enn mødre med blodtype 0. Regional forskningskonferanse innen medisin og helse 2006-11-01 - 2006-11-02 2006.

  • Killie, Mette K.; Kjeldsen-Kragh, Jens; Husebekk, Anne; Skogen, Bjørn Ragnar; Olsen, Jan Abel; Kristiansen, Ivar Sønbø. Cost-utility analysis of antenatal screening for Neonatal Alloimmune Thrombocytopenia. Regional forskningskonferanse innen medisin og helse 2006.

  • Kjeldsen-Kragh, Jens; Killie, Mette K.; Tomter, G; Golebiowska, E; Pedersen, Helene; Randen, I; Hauge, R; Aune, Berit; Øian, Pål; Dahl, Lauritz Bredrup; Pirhonen, J; Lindemann, R; Husby, H; Grønn, M; Skogen, Bjørn Ragnar; Husebekk, Anne. A screening and intervention program that significantly reduces mortality and serious morbidity associated with grave neonatal alloimmune thrombocytopenia. Regional forskningskonferanse innen medisin og helse 2006.

  • Husebekk, Anne; Killie, Mette K.; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar. General overview over screening programs. Vox Sanguinis 2006; Volum 91. ISSN 0042-9007.s 15 - 15.

  • Kjeldsen-Kragh, Jens; Killie, Mette K.; Skogen, Bjørn Ragnar; Husebekk, Anne. A screening and intervention program that significantly reduces mortality and serious morbidity associated with grave neonatal alloimmune thrombocytopenia. Vox Sanguinis 2006; Volum 91. ISSN 0042-9007.s 15 - 15.

  • Killie, Mette K.; Kjeldsen-Kragh, Jens; Husebekk, Anne; Skogen, Bjørn Ragnar; Olsen, Jan Abel; Kristiansen, ivar sØnbØ. Cost-utility analysis of antenatal screening for neonatal alloimmune thrombocytopenia. Vox Sanguinis 2006; Volum 91. ISSN 0042-9007.s 263 - 263.

  • Kjeldsen-Kragh, Jens; Killie, Mette K.; Skogen, Bjørn Ragnar; Husebekk, Anne. A sreening and intervention program that significantly reduces mortality and serious morbidity associated with grave neonatal alloimmune thrombocytopenia. 9th European Symposium on Platelet and Granulocyte Immunobiology 2006-06-15 - 2006-06-18 2006.

  • Kjeldsen-Kragh, Jens; Killie, Mette K.; Tomter, G; Golebiowska, E; Pedersen, H; Randen, I; Hauge, R; Aune, Berit; Øian, Pål; Dahl, Lauritz Bredrup; Pirhonen, J; Lindemann, R; Husby, H; Grønn, M; Skogen, Bjørn Ragnar; Husebekk, Anne. A screening and intervention program that significantly reduces mortality and serious morbidity associated with grave neonatal alloimmune thrombocytopenia. Regional forskningskonferanse innen medisin og helse 2006-11-01 - 2006-11-02 2006.

  • Husebekk, Anne; Killie, Mette K.; Kjeldsen-Kragh, Jens; Skogen, Bjørn Ragnar. General overview over screening programs. 9th European Symposium on platelet and Granulocyte Immunobiology 2006-06-15 - 2006-06-18 2006.

  • Killie, Mette K.; Kjeldsen-Kragh, Jens; Husebekk, Anne; Skogen, Bjørn Ragnar; Olsen, Jan Abel; Kristiansen, Ivar Sønbø. Cost-utility analysis of antenatal screening for Neonatal Alloimmune Thrombocytopenia. Regional forskningskonferanse innen medisin og helse 2006-11-01 - 2006-11-02 2006.

  • Gruber, F; Hansen, Hh; Olsen, M; Eggen, L; Skogen, Bjørn Ragnar; Gedde-dahl, T; Lundan, T; Porkka, K; Simonsson, B; Markevärn, B; Wadenvik, H; Stenke, L. Quantitative analysis of BCR-ABL mutations associated with imatinib treatment in CML. american society of hematology 2005-12-10 - 2005-12-13 2005.

  • Skogen, Bjørn Ragnar. Struktur og ressurser i transfusjonstjenesten i Helse Nord. Årsmøte i plasmafraksjoneringsprosjektet 2005-02-09 - 2005-02-09 2005.

  • Skogen, Bjørn Ragnar. Tanker fra de regionale helseforetakene. lederdagene 2005, NITO 2005-10-24 - 2005-10-26 2005.

  • Skogen, Bjørn Ragnar. Nye diagnostiske metoder i transfusjonsmedisin. Nasjonal Blodbankkonferanse 2005-09-22 - 2005-09-24 2005.

  • Husebekk, Anne; Kjeldsen-Kragh, J; Killie, Mette K.; Skogen, Bjørn Ragnar. Thrombocyte immunology – the role of antibodies related to transfusion and pregnancy. 15th ISBT European regional Conference 2005-07-04 - 2005-07-06 2005.

  • Kjeldsen-Kragh, J; Killie, Mette K.; Tomter, G; Golebiowska, E; Pedersen, H; Randen, I; Hauge, R; Aune, B; Oian, P; Dahl, LB; Pirhonen, J; Svennigsen, L; Wergeland, H; Lindeman, R; Husby, H; Gronn, M; Skogen, Bjørn Ragnar; Husebekk, Anne. A screening and intervention program reducing mortality and serious morbidity associated with neonatal alloimmune thrombocytopenia. American society of hematology 2005-12-10 - 2005-12-13 2005.

  • Aune, B.; Kjeldsen-Kragh, Jens; Killie, Mette Kjær; Øian, P; Dahl, L. B.; Pirhonen, Jouko; Svenningsen, Leif; WERGELAND, HÅKON; Lindemann, Rolf; Husby, H; Haugen, Guttorm; Grønn, Morten; Skogen, Bjørn; Husebekk, Anne. An intervention program for reducing morbidity and mortality associated with neonatal allo-immune thrombocytopenic purpura (NAITP). the 34th Congress of Nordic Federation of Societies of Obstretics and Gynecology 2004-06-12 - 2004-06-15 2004.

  • Kjeldsen-Kragh, Jens; Killie, Mette Kjær; Aune, B.; Oian, P; Dahl, L; Pirhonen, Jouko; Svenningsen, Leif; WERGELAND, HÅKON; Lindemann, Rolf; Husby, H; Haugen, Guttorm; Grønn, Morten; Skogen, Bjørn; Husebekk, Anne. An intervention program for reducing morbidity and mortality associated with neonatal alloimmune thrombocytopenic purpura (NAITP). Platelets 2004; Volum 15. ISSN 0953-7104.s 250 - .

  • Killie, Mette Kjær; Husebekk, Anne; Kjeldsen-Kragh, Jens; Skogen, Bjørn. The natural course of anti-HPA 1a antibody levels in subsequent non-compatible pregnancies. Platelets 2004; Volum 15. ISSN 0953-7104.s 250 - .

  • Killie, Mette Kjær; Kjeldsen-Kragh, Jens; Skogen, Bjørn; Husebekk, Anne. Maternal anti-HPA 1a antibody level as predictive value in neonatal alloimmune thrombocytopenic purpura (NAITP). Blood 2004; Volum 104. ISSN 0006-4971.s 570a - 571a.

  • Gruber, Franz; Lamark, Trond; Olsen, M; Hokkland, K; Skogen, Bjørn Ragnar. A RQ-PCR approach for quantitation of Glivec resistance associated mutations. Blood 2003; Volum 102. ISSN 0006-4971.s 416A - 417A.

  • [Loading...]